Table 1.
Characteristics of 949,309 Danish cancer patients diagnosed between 1980 and 2013, and matched cohort of cancer patients and cancer free Danish residents.
| All cancer patients | Matched cohorts | |||||
|---|---|---|---|---|---|---|
| Patients with specific cancer types* | Matched population comparisons | |||||
| N | % | N | % | N | % | |
| Total | 949,309 | 100 | 679,122 | 100 | 3,395,597 | 100 |
| Gender | ||||||
| Female | 490,351 | 52 | 344,842 | 51 | 1,724,208 | 51 |
| Male | 458,958 | 48 | 334,280 | 49 | 1,671,389 | 49 |
| Median age (interquartile range) | 67 (57, 76) | 68 (58, 76) | 68 (58, 76) | |||
| Age group, years | ||||||
| <50 | 134,602 | 14 | 84,021 | 12 | 420,889 | 12 |
| 50–59 | 157,616 | 17 | 111,176 | 16 | 555,402 | 16 |
| 60–69 | 255,269 | 27 | 186,794 | 28 | 934,335 | 28 |
| 70–79 | 254,144 | 27 | 187,990 | 28 | 939,871 | 28 |
| 80+ | 147,678 | 16 | 109,141 | 16 | 545,100 | 16 |
| Year of diagnosis | ||||||
| 1980–1994 | 346,494 | 37 | 232,586 | 34 | 1,162,921 | 34 |
| 1995–2001 | 183,789 | 19 | 128,478 | 19 | 642,388 | 19 |
| 2002–2009 | 267,059 | 28 | 200,955 | 30 | 1,004,773 | 30 |
| 2010–2013 | 151,967 | 16 | 117,103 | 17 | 585,515 | 17 |
| Charlson Comorbidity Index | ||||||
| No comorbidity (CCI= 0) | 706,123 | 74 | 501,106 | 74 | 2,628,460 | 77 |
| Mild comorbidity (CCI= 1) | 154,049 | 16 | 112,705 | 17 | 500,327 | 15 |
| Moderate comorbidty (CCI=2–3) | 75,150 | 7.9 | 55,192 | 8.1 | 228,482 | 6.7 |
| Severe comorbidity (CCI= ≥4) | 13,987 | 1.5 | 10,119 | 1.5 | 38,328 | 1.1 |
| Specific comorbid condition | ||||||
| Myocardial infarction | 39,099 | 4.1 | 29,546 | 4.4 | 142,097 | 4.2 |
| Congestive heart failure | 31,901 | 3.4 | 23,559 | 3.5 | 101,655 | 3.0 |
| Peripheral vascular disease | 34,456 | 3.6 | 25,828 | 3.8 | 100,550 | 3.0 |
| Cerebrovascular disease | 57,248 | 6.0 | 42,592 | 6.3 | 200,994 | 5.9 |
| Chronic pulmonary disease | 61,189 | 6.4 | 46,446 | 6.8 | 173,146 | 5.1 |
| Connective tissue disease | 22,618 | 2.4 | 16,602 | 2.4 | 72,543 | 2.1 |
| Ulcer disease | 38,399 | 4.0 | 26,798 | 3.9 | 109,417 | 3.2 |
| Mild liver disease | 9797 | 1.0 | 6462 | 1.0 | 20,312 | 0.6 |
| Diabetes I and II | 38,505 | 4.1 | 27,746 | 4.1 | 123,291 | 3.6 |
| Hemiplegia | 1867 | 0.2 | 1309 | 0.2 | 6091 | 0.2 |
| Moderate to severe renal disease | 12,898 | 1.4 | 9398 | 1.4 | 32,469 | 1.0 |
| Diabetes with end organ damage | 14,642 | 1.5 | 10,689 | 1.6 | 49,085 | 1.4 |
| Moderate to severe liver disease | 2674 | 0.3 | 1795 | 0.3 | 4668 | 0.1 |
| AIDS | 647 | 0.1 | 232 | 0.0 | 709 | 0.0 |
| Cancer stage† | ||||||
| Localized | 298,538 | 31 | 298,538 | 44 | ||
| Regional | 69,692 | 7.3 | 69,692 | 10 | ||
| Distant | 54,675 | 5.8 | 54,675 | 8.1 | ||
| Missing/Unknown | 526,404 | 56 | 256,217 | 38 | ||
| Receipt of any radiotherapy‡ | 51,512 | 14 | ||||
| Receipt of any chemotherapy‡ | 76,079 | 21 | ||||
| Median age at dementia diagnosis (interquartile range) | 83.1 (77.9, 87.5) | 83.5 (78.6, 87.7) | ||||
| Median follow-up time (interquartile range) | 2.8 (0.60, 8.0) | 3.1 (0.70, 8.1) | 7.2 (3.3, 13.2) | |||
*
Prostate cancer (n=68,895), Lung cancer (n=103,428), colon cancer (n=67,315), pancreatic cancer (n=22,114), breast cancer (n=109,755), non-melanoma skin cancer (n=195,899), brain cancer (n=12,433), leukemia (n=21,660), melanoma (n=30,586), liver cancer (n=7,824), kidney cancer (n=15,728), bladder cancer (n=23,485).
†
Only solid cancer. Other cancer types are included in the missing/unknown category.
‡
Received within three months of cancer diagnosis. Restricting to patients diagnosed from 2004 onwards due to data availability.